What are the health risks of cigar smoking and the recommended cessation approach?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Health Risks of Cigar Smoking and Cessation Approach

Cigar smoking poses significant cardiovascular and respiratory risks comparable to cigarettes, including increased mortality, coronary heart disease, stroke, COPD, and lung cancer—cessation should follow the same evidence-based approach as cigarette smoking using combination pharmacotherapy (nicotine replacement therapy or varenicline) plus behavioral counseling. 1, 2, 3

Detrimental Health Effects of Cigars

Cardiovascular Risks

  • Coronary heart disease events occur with cigar use, though to a slightly lesser degree than cigarette smoking 1
  • Meta-analyses demonstrate increased CHD risk with smokeless tobacco and cigar use 1
  • Switching from cigarettes to pipes or cigars confers little to no benefit—a British Regional Heart Study found pipe/cigar switchers had a 3.3-fold increased stroke risk, similar to light cigarette smokers 4
  • Cigar smoking adversely affects endothelial function, promotes atherosclerosis, and is prothrombotic 1

Respiratory and Mortality Risks

  • Exclusive pipe/cigar users without cigarette history show accelerated lung function decline: 3.36 mL/year faster FEV1 decline and 3.73 mL/year faster FVC decline compared to never-tobacco users 5
  • All-cause mortality increases by 24% (HR 1.24) among exclusive cigar users 5
  • COPD hospitalization/mortality risk doubles (HR 2.02) in cigar-only smokers 5
  • Preserved ratio impaired spirometry risk increases 83% (HR 1.83) 5

Cancer Risks

  • All combustible tobacco products, including cigars, hookah, and pipes, cause at least 30% of all cancer deaths 2
  • Cigars pose similar health risks to cigarettes for malignancies 6

Critical Misconception

A dangerous knowledge gap exists: Many cigar smokers, particularly young adults using cigarillos and blunts, do not believe cigar smoking is risky behavior and show uncertainty about product harms and addictiveness relative to cigarettes 7, 8, 9. This is especially problematic in Black young adult populations who have high cigar prevalence but receive minimal cessation assistance from healthcare providers 8.

Recommended Cessation Approach

Systematic Screening and Assessment

  • Screen ALL patients for tobacco use at every clinical encounter, including specific assessment for cigars, pipes, hookah, and smokeless tobacco—not just cigarettes 1, 2
  • Document smoking status in the health record and update at regular intervals 2
  • Assess nicotine dependency: amount smoked daily, time to first use after waking, use of other tobacco/nicotine products 2
  • Evaluate quit history: longest abstinence period, previous quit attempts, methods used, reasons for failure 2

Evidence-Based Cessation Strategy

The most effective approach combines pharmacotherapy with behavioral therapy 2, 10—this is not optional but the standard of care.

Preferred Primary Pharmacotherapy Options:

  1. Combination NRT (long-acting patch PLUS short-acting form for breakthrough cravings—gum, lozenge, inhaler, or nasal spray) 2
  2. Varenicline (12-week initial course) 2, 10, 2

Try both preferred options before considering alternatives 2. Bupropion is a secondary option 10.

Behavioral Therapy Requirements:

  • High-intensity counseling with multiple sessions is most effective, but minimum brief counseling is mandatory 2
  • Utilize telephone quitlines (1-800-QUIT-NOW), web-based programs (Freedom From Smoking, Smokefree.gov), or in-person counseling 1
  • Behavioral resources should be provided at every pharmacotherapy initiation 2

Follow-Up Protocol

  • Initial follow-up within 2-3 weeks of starting therapy to assess efficacy, toxicity, and withdrawal symptoms 2
  • Continue periodic assessment at no more than 12-week intervals 2
  • Assess adherence, adjust doses as needed, and address side effects 2
  • Relapse is expected and normal—smoking slips do not necessarily indicate need for alternative methods; multiple quit attempts with the same therapy may be required 2

Special Considerations

Surgical Patients:

  • Cessation should occur as far in advance of surgery as feasible 2
  • Do NOT delay appropriate cancer surgery based on smoking status 2
  • NRT at normal doses does not negatively affect acute wound healing 2

Contraindications:

  • Avoid varenicline and bupropion in patients with brain metastases (increased seizure risk) 2
  • Manage nausea from varenicline in patients receiving chemotherapy 2

Healthcare Provider Responsibilities

A critical gap exists: Most healthcare providers do not screen for cigar use specifically, and even when aware, provide little cessation assistance 8. This must change.

  • Deliver clear, strong, personalized advice: "Cigar smoking increases your risk of heart attack, stroke, and lung disease. Quitting is the single most important thing you can do to protect your health" 3
  • Prescribe approved medications (combination NRT, varenicline, bupropion, or cytisine where available) 11
  • Refer to specialized smoking cessation clinics for patients who fail brief interventions 12

Benefits of Cessation

  • Smoking cessation after MI reduces mortality by 36% and MI recurrence by 32% 1
  • Stroke risk in light cigar smokers returns to never-smoker levels within 5 years of complete cessation 4
  • Benefits occur at any age—it is never too late to quit, even for patients with advanced disease or end-of-life care 2

Common Pitfall to Avoid

Switching from cigarettes to cigars or pipes is NOT harm reduction—the cardiovascular and respiratory risks remain substantially elevated 4. Complete cessation of all combustible tobacco is required 2, 3.

References

Guideline

smoking cessation, version 1.2016, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

Research

Cigar smoking: an ignored public health threat.

The journal of primary prevention, 2005

Related Questions

In a 12‑month‑old male with normal growth and exam, which absent developmental milestone (e.g., pointing to a body part, responding to name, stacking two blocks, using a cup, or walking independently) would be most concerning and warrant further investigation?
In a 13‑day‑old infant presenting with fever and poor feeding, what interventions should emergency medical services (EMS) perform?
How should I manage a 10-month-old infant with a rectal temperature of 100.6 °F and two episodes of vomiting?
What are the differential diagnoses for aggressive behavior in a 10-year-old child?
In a 19-year-old college student with fever (103°F), severe headache, altered mental status, hypotension (90/55 mmHg), sluggish pupils, and leukocytosis with 20% band forms, what isolation precautions are indicated?
What is the best alternative to Bijuva (estradiol/progesterone) hormone replacement therapy for a 58-year-old woman with an intact uterus who is currently on backorder?
How can I tell if cellulitis is resolving?
What are the side effects of tetracycline, metronidazole, and bismuth compounds used in Helicobacter pylori eradication therapy?
What are the recommended dosing guidelines for ramelteon in adults, including dose adjustments for hepatic impairment and contraindications?
In patients with febrile neutropenia, when should MRSA‑active therapy be added and what are the preferred MRSA‑active agents?
Can sepsis be used as a terminal diagnosis to qualify a patient for hospice admission?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.